External stimuli like loud noises and strong odors cause migraine sensory overload, affecting your sense of touch, smell, ...

“Ubrogepant 100 mg, when administered in the premonitory (prodromal) phase of migraine, before a headache has commenced, may treat symptoms such as photophobia, phonophobia, and cognitive dysfunction, ...

Results from a phase III clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent ...

A migraine drug called ubrogepant doesn't just reduce the severity of a migraine attack – it also dials down the non-headache ...

Gensco Laboratories LLC d/b/a Gensco Pharma, (Gensco or the Company) a leader in specialty pharmaceuticals, proudly announces ...

A new study published in the Journal of American Medical Association showed that rizatriptan did not effectively relieve ...

Ubrogepant, approved for acute treatment of migraine, may also reduce nonheadache symptoms that occur in the hours preceding ...

Absence of phonophobia occurred in 50.7 and 35.8% of events at four hours postdose (odds ratio, 1.97); and at 24 hours post-dose, absence of dizziness occurred in 88.5 and 82.3% of events (odds ...

RizaFilm is particularly beneficial for patients experiencing migraine-associated nausea, photophobia, and phonophobia. The global migraine drugs market was valued at nearly $5.65 billion in 2023 ...

Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent ...